Phase
Condition
Arrhythmia
Chest Pain
Dysrhythmia
Treatment
1. electrical/pharmacological cardioversion. 2.pulmonary vein isolation
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with estabolished diagnosis of Persistent Atrial Fibrillation during past 6mnths.
LAD brfore entering the two cohorts is more than 40mm, and less than 50mm.
Pharmacological or electrical cardioversion has be performed successfully.
At least two echocardiograms were performed before and 3-6 months aftercardioversion., and confirm the status of LAD (Reversal, unchange, enlargment).
Patients have given informed consent.
Exclusion
Exclusion Criteria:
Prior radiofrequency ablation treatment for atrial fibrillation
Prior cardiac surgical procedures
Individuals with cognitive impairments who are unable to give informed consent
Study Design
Study Description
Connect with a study center
The Second Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing 400072
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.